GB1296505A - - Google Patents

Info

Publication number
GB1296505A
GB1296505A GB1296505DA GB1296505A GB 1296505 A GB1296505 A GB 1296505A GB 1296505D A GB1296505D A GB 1296505DA GB 1296505 A GB1296505 A GB 1296505A
Authority
GB
United Kingdom
Prior art keywords
weight
dopa
june
talc
magnesium stearate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1296505A publication Critical patent/GB1296505A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
GB1296505D 1970-06-10 1971-06-09 Expired GB1296505A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4524470A 1970-06-10 1970-06-10

Publications (1)

Publication Number Publication Date
GB1296505A true GB1296505A (de) 1972-11-15

Family

ID=21936793

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1296505D Expired GB1296505A (de) 1970-06-10 1971-06-09

Country Status (8)

Country Link
US (1) US3632778A (de)
BE (1) BE768269A (de)
DE (1) DE2128461A1 (de)
DK (1) DK126236B (de)
ES (1) ES392066A1 (de)
FR (1) FR2100742B1 (de)
GB (1) GB1296505A (de)
NL (1) NL7107643A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
US4017636A (en) * 1973-10-23 1977-04-12 Abbott Laboratories Esters of γ-glutamyl amide of dopamine
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
DE2513940A1 (de) * 1975-03-29 1976-10-14 Merck Patent Gmbh Pharmazeutische zubereitung
US4097606A (en) * 1975-10-08 1978-06-27 Bristol-Myers Company APAP Tablet containing an alkali metal carboxymethylated starch and processes for manufacturing same
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
DE2551446B2 (de) * 1975-11-15 1977-09-15 Karl Werner Schlüter GmbH, 2000 Ham burg Verfahren zur herstellung von suppositorien
JPS5332111A (en) * 1976-09-07 1978-03-27 Asahi Chem Ind Co Ltd Composition for tablet
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
US4195078A (en) * 1979-03-09 1980-03-25 Eli Lilly And Company Nabilone granulation
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4327080A (en) * 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4736527A (en) * 1982-12-13 1988-04-12 Konishiroku Photo Industry Co., Ltd. Apparatus for the heat treatment of powdery material
DE3767998D1 (de) * 1986-12-20 1991-03-14 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
HU209564B (en) * 1991-01-30 1994-07-28 Egyt Gyogyszervegyeszeti Gyar Process for producing rapide tablets containing levodopa and carbidopa
HUE048950T2 (hu) * 2014-05-29 2020-09-28 Novartis Ag Ceritinib formuláció

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine

Also Published As

Publication number Publication date
US3632778A (en) 1972-01-04
DK126236B (da) 1973-06-25
BE768269A (fr) 1971-12-09
FR2100742B1 (de) 1974-09-06
NL7107643A (de) 1971-12-14
FR2100742A1 (de) 1972-03-24
DE2128461A1 (de) 1971-12-16
ES392066A1 (es) 1974-10-16

Similar Documents

Publication Publication Date Title
GB1296505A (de)
GB906422A (en) Improvements in and relating to prolonged acting pharmaceutical preparations
NO176203C (no) Fremgangsmåte for fremstilling av ibuprofentabletter med forsinket frigjöring
ES424533A1 (es) Metodo de prolongar la disponibilidad de sustancias farmaco-logicamente activas incluidas en composiciones farmaceuticasa base de alcohol alifatico e hidroxialcohilcelulosa.
KR840005661A (ko) 지속성 매트릭스 정제 조성물의 제조방법
ES8104911A1 (es) Procedimiento para preparar una composicion terapeutica de liberacion retardada, conformada y comprimida, que contiene una sustancia terapeuticamente activa incorporada en un ma- terial excipiente de hidroxipropilmetilcelulosa
KR850000975A (ko) 발프로익산과 그 염의 혼합물을 토대로 한 조성물
ES423856A1 (es) Procedimiento para la elaboracion de medicamentos con ce- sion retardada de la sustancia activa en el instestino.
HUP0105463A2 (hu) Divalproex-nátriumot tartalmazó szabályozott felszabadulású készítmény
GB1380171A (en) Medicinal tablets
GB1507418A (en) Process for producing tablets and suppositories and a composition for use therein
GB1209093A (en) Pharmaceutical preparation
US3396226A (en) Nongranulated compressed tablets of ascorbic acid with microcrystalline cellulose
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
GB1480175A (en) Compositions in the form of coated tablets
ES395533A1 (es) Un procedimiento para preparar composiciones farmaceuticas de liberacion prolongada a base de acido acetilsalicilico.
GB1355985A (en) Solid slow release preparation of prolonged action
DE3274185D1 (en) Medicinal preparations for glycoside-hydrolase inhibitors
GB1021924A (en) Improvements in or relating to method of preparing sustained release tablets
DE938566C (de) Verfahren zur Herstellung von lager- und zerfallfaehigen Arzneimitteltabletten
IE35419L (en) Pharmaceutical composition containing cyclobenzaprine
US3740432A (en) Vitamin complexes of niacinamide,riboflavin and sodium ascorbate
GB1327560A (en) Effervescent pharmaceutical preparations
KR840001829A (ko) 새로운 이펜프로딜을 함유하는 정제의 제조방법
JPS55122726A (en) Prolonged release drug composition

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]